DRUG TRANSPORT IN THE KIDNEY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 491

149. Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh
M, Onozato ML, Tojo A, et al. 2004. Interactions of human organic anion transporters
with diuretics. J Pharmacol Exp Ther 308:1021-1029.
150. De Zeeuw D, Jacobson HR, Brater DC. 1988. Indomethacin secretion in the isolated
perfused proximal straight rabbit tubule, incidence for two parallel transport mechanisms.
J Clin Invest 81:1585-1592.
151. Cox PGF, Van Os CH, Russel GM. 1992. Accumulation of salicylic acid and indomethacin
in isolated proximal tubular cells of the rat kidney. Pharmacol Res 27:241-252.
152. Ferrier B, Martin M, Roch-Ramel F. 1983. Effects of p -aminohippurate and pyrazinoate
on the renal excretion of salicylate in the rat: a micropuncture study. J Pharmacol Exp
Ther 224:451-458.
153. Schild L, Roch-Ramel F. 1988. Transport of salicylate in proximal tubule (S2 segment)
isolated from rabbit kidney. Am J Physiol 254:F554-F561.
154. Despopoulos A. 1960. Renal metabolism of salicylate and salicylurate. Am J Physiol
198:230-232.
155. Putney JW Jr, Borzelleca JF. 1973. Active accumulation of [ 14 C]-salicylic acid by rat
kidney cortex in vitro. J Pharmacol Exp Ther 186:600-608.
156. Chatton J, Roch-Ramel F. 1992. Transport of salicylic acid through monolayers of a
kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 261:518-524.
157. Bito LZ, Salvador EV. 1976. Effects of anti-inflammatory agents and some other drugs
on prostaglandin biotransport. J Pharmacol Exp Ther 198:481-488.
158. Nierenberg DW. 1987. Drug inhibition of penicillin tubular secretion: concordance be-
tween in vitro and clinical findings. J Pharmacol Exp Ther 240:712-716.
159. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou
H. 1999. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion
transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 55:847-854.
160. Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, Piyachaturawat
P, Endou H. 2002. Interactions of human organic anion transporters and human organic
cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther
303:534-539.
161. Safrin S. 2001. Antiviral agents. In: Katzung BG, editor. Basic and Clinical Pharmacol-
ogy , 8th ed. New York: McGraw-Hill, pp 823-849.
162. de Miranda P, Godd SS, Yarchoan R, Thomas RV, Blum MR, Myers CE, Broder S.
1989. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS
or AIDS-related complex. Clin Pharmacol Ther 46:494-500.
163. Laskin OL, de Miranda P, King DH, Page DA, Longstreth JA, Rocco L, Lietman PS. 1982.
Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
Antimicrob Agents Chemother 21:804-807.
164. Yarchoan R, Mitsuya H, Myers CE, Broader S. 1989. Clinical pharmacology of 3 -
azido-2 ,3 -dideoxythymidine (Zidovudine) and related dideoxynucleosides. N Engl J
Med 321:726-738.
165. Morse GD, Shelton MJ, O'Donnell AM. 1993. Comparative pharmacokinetics of antiviral
nucleoside analogues. Clin Pharmacokinet 24:101-123.
166. Chatton J, Odone M, Besseghir K, Roch-Ramel F. 1990. Renal secretion of 3 -azido-3 -
deoxythymidine by the rat. J Pharmacol Exp Ther 255:140-145.